Are Medical Stocks Lagging Bayer (BAYRY) This Year?
Here is how Bayer Aktiengesellschaft (BAYRY) and Align Technology (ALGN) have performed compared to their sector so far this year.
Bayer Aktiengesellschaft (BAYRY) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Bayer Aktiengesellschaft (BAYRY) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Bayer Aktiengesellschaft (BAYRY) is a Great Momentum Stock: Should You Buy?
Does Bayer Aktiengesellschaft (BAYRY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Best Value Stocks to Buy for January 21st
BNPQY, BAYRY and DLAKY made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 21, 2026.
Bayer Shares Jump as Supreme Court Agrees to Review Key Roundup Case
BAYRY jumps 6.4% after the Supreme Court agrees to review the Durnell Roundup case, a key test of federal preemption in glyphosate litigation.
Supreme Court to hear Bayer's appeal to block thousands of Roundup weedkiller lawsuits
Bayer is arguing that consumers should not be able to sue it under state law for failing to warn that Roundup increases cancer risk because the Environmental Protection Agency has found no such risk and requires no such warning.
US Supreme Court to hear Bayer's bid to curb Roundup cases
The U.S. Supreme Court agreed on Friday to hear Bayer's bid to sharply limit lawsuits claiming that the company's Roundup weedkiller causes cancer and potentially avert billions of dollars in damages.
Bayer Stock Jumps on Nubeqa Outlook, Presents Pharma Strategy
BAYRY jumps 6.6% after partner Orion said Nubeqa sales tied to Bayer could top ???1B long term.
Bayer Shares Surge as Partner Forecasts Sales Growth for Prostate-Cancer Drug
Orion predicted strong growth for darolutamide, the prescription prostate-cancer medication it co-developed with Bayer.
Bayer Accelerates Growth With siRNA, AI Deals and Pipeline Progress
Bayer AG enters into collaborations to develop a heart-targeted siRNA therapy and AI technology, expanding its push into next-gen genetic medicines.
Here's Why Bayer Aktiengesellschaft (BAYRY) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
